Cargando…
Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic
BACKGROUND AND AIMS: Substance use disorders (SUDs) affect approximately 40.3 million people in the USA, yet only approximately 19% receive evidence-based treatment each year. reSET(®) is a prescription digital therapeutic (PDT) and the only FDA-authorized treatment for patients with cocaine, cannab...
Autores principales: | Shah, Neel, Velez, Fulton F., Colman, Samuel, Kauffman, Laura, Ruetsch, Charles, Anastassopoulos, Kathryn, Maricich, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273919/ https://www.ncbi.nlm.nih.gov/pubmed/35819569 http://dx.doi.org/10.1007/s12325-022-02215-0 |
Ejemplares similares
-
Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic
por: Velez, Fulton F., et al.
Publicado: (2022) -
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder
por: Velez, Fulton F, et al.
Publicado: (2021) -
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders
por: Xiong, Xiaorui, et al.
Publicado: (2022) -
Real-World Evaluation of Clinical Response and Long-Term Healthcare Resource Utilization Patterns Following Treatment with a Digital Therapeutic for Chronic Insomnia
por: Forma, Felicia, et al.
Publicado: (2022) -
FDA regulations and prescription digital therapeutics: Evolving with the technologies they regulate
por: Watson, Anthony, et al.
Publicado: (2023)